Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
On Saturday, September 16, 2017, patients, caregivers, family members and friends joined GRACE in Cleveland at the Taussig Cancer Center for a full day of discussion on Targeted Therapies in Lung Cancer. We are thrilled that people joined us for this amazing and informative day. Huge thanks to all of the faculty who spent their Saturday in Cleveland with our community, and thanks also to those organizations who sponsored this event - Astra Zeneca, Takeda, Boehringer Ingelheim, Ignyta, Novartis, Genentech, Caris, and Guardant Health.
We started the day out with a warm welcome from our Forum Chair - Dr. Nathan Pennell. For the full agenda, faculty list, presentations, and videos from the webcast, please visit the 'webcast details' page, available via this link.
The morning sessions continued:
The Many Faces of Progression
Dr. Nathan Pennell, Cleveland Clinic Cancer Center
The Role of Local Therapy
Dr. Shirish Gadgeel, Michigan Medicine, University of Michigan
Biopsies & Re-biopsies
Dr. Karen Reckamp, City of Hope Comprehensive Cancer Center
The Question of Clinical Trials
Dr. Alice Shaw, Massachusetts General Hospital
The Crossroads:
Local Therapy, Chemo, Targeted Therapy, or Immunotherapy?
Panel Discussion with Drs. Pennell, Gadgeel, Reckamp, and Shaw, and patients John Cherol (EGFR), Matt Hiznay (ALK), and Sara Whitlock (RET). Moderator: Dr. H. (Jack) West
Lunch was an opportunity to have further discussion with the faculty. Cleveland Clinic Cancer Center graciously allowed us to set up lunch on the 1st floor in their beautiful new facility.
After lunch the breakout discussions continued:
Dr. Alice Shaw, Dr. Shirish Gadgeel, and Matt Hiznay, ALK patient
Dr. Nathan Pennell, Dr. H. (Jack) West, and John Cherol, EGFR patient
Dr. Karen Reckamp, Dr. Vamsidhar Velcheti, and Sara Whitlock, RET patient
The day concluded with the afternoon general session:
Managing the Cost of Cancer Care
Dr. James P. Stevenson, Cleveland Clinic Cancer Center
Patient to Patient Mentoring
Kathryn Sefcek, MHA, 4th Angel Mentoring Program
Caveat Emptor: Assessing Cancer Information from Sources of Varying Quality
Dr. H. (Jack) West, Swedish Cancer Institute & Founder of cancerGRACE, and Janet Freeman-Daily, ROS1 patient, #LCSM Twitter Chat co- moderator, Cure Today contributor, blogger
Please click here to visit the Targeted Therapies in Lung Cancer Webcast page for viewing the videos in full! (Please note, we will be editing the videos to cut them down - they are in raw format at this time).
Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…